
Oasis Pharmaceuticals Limited
Manufactures and markets ayurvedic and allopathic medicines, drugs, vaccines, and diagnostic products.
Manufactures and markets ayurvedic and allopathic medicines, drugs, vaccines, and diagnostic products.
Oasis Pharmaceuticals Limited (OPL) is a Public Limited Indian Non-Government Company incorporated in India on 31 January 1994 and has a history of 31 years and two months. Its registered office is in Delhi, India.
The Corporate was formerly known as Oasis Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 3.84 Cr.
The company has closed loans amounting to ₹7.40 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Alok Narain, Avinash Lohia, and Swati Pasari serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U74899DL1994PLC057156
057156
Public Limited Indian Non-Government Company
31 Jan 1994
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Alok Narain ![]() | Director | 31-Jan-1994 | Current |
Avinash Lohia ![]() | Director | 24-Apr-2017 | Current |
Swati Pasari ![]() | Additional Director | 02-Dec-2024 | Current |
Oasis Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 101.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.39%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Oasis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Swati Pasari is a mutual person
Avinash Lohia and Swati Pasari are mutual person
Alok Narain is a mutual person
Avinash Lohia is a mutual person
Avinash Lohia is a mutual person
Avinash Lohia is a mutual person
₹0
₹0.74 Cr
Date | Lender | Amount | Status |
---|---|---|---|
08 Oct 1997 | Indian Overseas Bank | ₹2.40 M | Satisfied |
08 Oct 1997 | Indian Overseas Bank | ₹5.00 M | Satisfied |
Oasis Pharmaceuticals has a workforce of 1 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Oasis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oasis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Swati Pasari was appointed as a Additional Director was appointed as a Additional Director on 02 Dec 2024 & has been associated with this company since 4 months 25 days .
Oasis Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Oasis Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Avinash Lohia was appointed as a Director was appointed as a Director on 24 Apr 2017 & has been associated with this company since 8 years 2 days .
A charge registered on 08 Oct 1997 via Charge ID 80027412 with Indian Overseas Bank was fully satisfied on 05 May 2008.
A charge registered on 08 Oct 1997 via Charge ID 80027415 with Indian Overseas Bank was fully satisfied on 05 May 2008.
Oasis Pharmaceuticals Limited was incorporated on 31 Jan 1994.
The authorized share capital of Oasis Pharmaceuticals Limited is ₹ 6.00 Cr and paid-up capital is ₹ 3.84 Cr.
Currently 3 directors are associated with Oasis Pharmaceuticals Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Oasis Pharmaceuticals Limited is 4239-A 1 Ansari Road Daryaganj, India, New Delhi, 110002.
The corporate identification number (CIN) of Oasis Pharmaceuticals Limited is U74899DL1994PLC057156 and the company number is 057156 as per Ministry of Corporate Affairs (MCA).
As Per 2023 financial reports, 1 employees are currently employed by Oasis Pharmaceuticals Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Oasis Pharmaceuticals Limited has experienced an downturn of -12.39%.
The most recent Balance Sheet for Oasis Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
SJ
KA
NP
VN
SP
SP
SA
AL